Please login to the form below

Not currently logged in
Email:
Password:

drug delivery

This page shows the latest drug delivery news and features for those working in and with pharma, biotech and healthcare.

Redmile and Google help Evox raise £35.5m for exosome pipeline

Redmile and Google help Evox raise £35.5m for exosome pipeline

Evox is developing a new drug delivery platform based on extracellular vesicles (exosomes) that are used by cells to transport molecular ‘cargo’between them, typically substances that are simply too big ... The Series B funding will also be used to

Latest news

More from news
Approximately 3 fully matching, plus 193 partially matching documents found.

Latest Intelligence

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Alnylam was also forced to abandon one of its first pipeline drugs, revusiran, after it was linked to deaths in trials, but persisted, developing a safer and more potent drug delivery ... platform. Led by founder and CEO John Maraganore, Alynlam finally

  • The true potential of mobile health tech The true potential of mobile health tech

    If it works, we will get better drug delivery, improved adherence, more committed patients and a reduction of waste.

  • How Augmented reality is disrupting healthcare How Augmented reality is disrupting healthcare

    2. Improve understanding of complex treatments. Unprecedented scientific discovery has led to an increased focus on developing specialised treatments that are highly complex - both in action and in delivery. ... Think of the value of virtually

  • A new era of smart pharma A new era of smart pharma

    Blending Reportum with AI and Robotic tools affords pharma companies the opportunity to transform their end-to-end drug safety processes today. ... Medical adherence is being improved. Drug delivery technology has improved significantly in recent years.

  • A quest for innovative solutions A quest for innovative solutions

    to more than 300 with the creation of PRISM (Patient Relevant Innovative Solutions Mission) which seeks out the nuggets of therapeutic value and delivery innovation. ... Technology’s attractive calling card is the monitoring and collection of data that

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest appointments

  • Concept Life Sciences adds to its scientific and commercial team Concept Life Sciences adds to its scientific and commercial team

    Dr Calvert has experience in the delivery of integrated drug discovery and development solutions, supporting organisations ranging from virtual companies to global pharma. ... He joins Concept from Aptuit, where he held various roles including senior

  • Philips promotes Simon McGuire to health systems lead Philips promotes Simon McGuire to health systems lead

    Philips promotes Simon McGuire to health systems lead. He was previously GM at Philips Respironics Respiratory Drug Delivery. ... McGuire was previously Philips' general manager of respiratory drug delivery in sleep and respiratory care, having joined

  • Albumedix appoints Dr Giles Campion as CMO Albumedix appoints Dr Giles Campion as CMO

    Dr Campion will be responsible for the firm's global development efforts, with a particular focus on its albumin-based drug delivery platform. ... He brings over 25 years of drug development experience to the role, most recently as group vice president

  • Catalent appoints two board members Catalent appoints two board members

    Catalent appoints two board members. Jack Stahl and Rolf Classon to advise drug development, delivery and supply company. ... Jack Stahl, former CEO of cosmetics firms Revlon, and Rolf Classon, former chairman at Bayer Healthcare, will use to their

  • MedImmune appoints Dr Anand Subramony MedImmune appoints Dr Anand Subramony

    MedImmune appoints Dr Anand Subramony. He joins from Novartis to take up drug delivery and device development role. ... AstraZeneca's MedImmune unit has appointed Dr Anand Subramony as its new vice president of drug delivery and device development.

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics